PRENETICS GLOBAL news, videos and press releases
For more news please use our advanced search feature.
PRENETICS GLOBAL - More news...
PRENETICS GLOBAL - More news...
- Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
- Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham
- Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials
- Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
- Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
- Prenetics Announces Participation in December Investor Conferences
- Prenetics Announces Third Quarter 2024 Financial Results
- MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
- Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
- Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
- Prenetics Announces Second Quarter 2024 Financial Results
- Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
- Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
- Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
- Prenetics Announces First Quarter 2024 Financial Results
- Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
- Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
- Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
- Prenetics Announces Third Quarter 2023 Financial Results
- Prenetics Global Limited Announces Reverse Stock Split
- Prenetics Announces Second Quarter 2023 Financial Results
- Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
- Prenetics Announces First Quarter 2023 Financial Results
- Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
- Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
- Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
- Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
- Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
